Biotest's market cap is currently ―. The company's EPS TTM is €1.731; its P/E ratio is ―; and it has a dividend yield of 0.29%. Biotest is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 155.30M	$ 107.70M	$ 137.20M	$ 115.90M	$ 144.20M
Gross Profit	$ 44.20M	$ 23.60M	$ 30.80M	$ 26.20M	$ -1.00M
EBIT	$ -5.00M	$ -4.40M	$ -1.20M	$ -600.00K	$ -43.10M
EBITDA	$ -5.00M	$ -4.40M	$ -1.20M	$ -600.00K	$ -43.10M
Net Income Common Stockholders	$ 2.10M	$ -14.30M	$ -15.00M	$ -4.90M	$ -35.50M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 136.60M	$ 76.90M	$ 103.10M	$ 130.10M	$ 117.50M
Total Assets	$ 1.20B	$ 1.08B	$ 1.10B	$ 1.11B	$ 1.10B
Total Debt	$ 574.30M	$ ―	$ ―	$ ―	$ 496.30M
Net Debt	$ 437.70M	$ ―	$ ―	$ ―	$ 378.80M
Total Liabilities	-	-	-	-	-
Stockholders Equity	$ 371.10M	$ 343.80M	$ 358.70M	$ 375.10M	$ 380.40M
Cash Flow	-
Free Cash Flow	$ -53.00M	$ -18.70M	$ -18.10M	$ 20.00M	$ 12.40M
Operating Cash Flow	$ -23.70M	$ -18.70M	$ -18.10M	$ 20.00M	$ 30.60M
Investing Cash Flow	$ -12.20M	$ -9.30M	$ -7.80M	$ -7.70M	$ -4.00M
Financing Cash Flow	$ 99.20M	$ -3.80M	$ -4.30M	$ -1.50M	$ -1.50M

Currency in USD

Biotest Earnings and Revenue History

Income Statement >

Biotest Debt to Assets

Balance Sheet >

Biotest Cash Flow

Cash Flow >

Biotest Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing